Profile of Immunoglobulin G and IgM Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
- PMID: 32337590
- PMCID: PMC7197626
- DOI: 10.1093/cid/ciaa489
Profile of Immunoglobulin G and IgM Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
Abstract
We profiled the serological responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleocapsid (N) protein and spike (S) glycoprotein. The majority of the patients developed robust antibody responses between 17 and 23 days after illness onset. Delayed, but stronger, antibody responses were observed in critical patients.
Keywords: COVID-19; IgG; IgM; SARS-CoV-2; serologic responses.
© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.
Comment in
-
The role of SARS-CoV-2 antibodies in COVID-19: Healing in most, harm at times.Respirology. 2020 Jul;25(7):680-682. doi: 10.1111/resp.13852. Epub 2020 May 20. Respirology. 2020. PMID: 32436320 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
